Interpace Biosciences (IDXG, $2.65) was a top loser this month, diving -1 to $2.65 per share. Of the 418 stocks analyzed in the Medical Specialties Industry throughout this month, of them (4) exhibited an Uptrend while of them (5) were in a Downtrend.